Simplex Trading
MLNT

Simplex Trading’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Simplex Trading’s Portfolio MLNT Stock Details MLNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-892
Closed -$3.4K – 8238
2019
Q1 		$3K Buy
+892
New +$4.84K ﹤0.01% 6730
2018
Q4 		– Sell
-156
Closed -$2K – 8282
2018
Q3 		$3K Buy
156
+35
+29% +$885 ﹤0.01% 7024
2018
Q2 		$3K Buy
+121
New +$4.36K ﹤0.01% 6991

Simplex Trading's MLNT Position: Q2 2019 in Review

Simplex Trading sold out of Melinta Therapeutics, Inc. Common Stock (MLNT) in Q2 2019, closing a stake of 892 shares — an estimated $3.4K sold.

Simplex Trading first reported a position in MLNT in Q2 2018 and held it in 3 quarters. The position peaked at $3K in Q1 2019. 53 funds tracked by Wall St. Rank hold MLNT as of Q2 2019.

  • Simplex Trading reported no remaining Melinta Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Simplex Trading sold 892 Melinta Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $3.4K.
  • Simplex Trading first reported a position in Melinta Therapeutics, Inc. Common Stock in Q2 2018 and held it in 3 quarters.
  • Simplex Trading's Melinta Therapeutics, Inc. Common Stock position peaked at $3K in Q1 2019.
  • 53 funds tracked by Wall St. Rank held Melinta Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Simplex Trading's 13F filing for Q2 2019, filed 26 Jul 2019.